Tempus Labs - TEM Net earnings per share (EPS TTM)

Public company logo of Tempus Labs (TEM)

The annual volatility of TTM net income per share for Tempus AI, Inc (TEM) reflects market expectations, where the value 10.50 represents the latest figure. This trend is supported by oncologists' confidence in precise data analytics and a formidable AI barrier to entry for new players. Growth is driven by the company's ownership of a global library of molecular data, which distinguishes Tempus AI, Inc (TEM) from other precision medicine developers.

TEM Tempus: Net earnings per share for the last 12 months in the range 11/23/2025 - 11/13/2026

TEM (Tempus Labs): analytical breakdowns and indicator data

- current price and projected stock value:
Price Performance Chart Tempus AI, Inc.|TEM - Analyst Consensus Forecast
- issuer market value details:
Market Capitalization Tempus AI, Inc.|TEM - Enterprise Value
- shareholders' equity book value data:
Net Assets per Share Tempus|TEM - Company Net Assets|Market Value to Book Value tempus.com|TEM - Company Total Assets
- company total debt and liquidity indicators:
Total Debt to Capital Coefficient Tempus AI, Inc|TEM - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Tempus AI, Inc|TEM - Company Aggregate Debts|Debt to Book Value Tempus AI, Inc.|TEM - Company Long-Term Liabilities|Amount of Current Liabilities Tempus|Immediate Liquidity tempus.com
- business earnings and investment ratios data:
TEM - Company Net Income|Future Profit Tempus AI, Inc|TEM - P/E Multiple|Price to Future Earnings Ratio Tempus AI|TEM - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Tempus AI, Inc.|TEM - Operating profit EBITDA|Net earnings per share (EPS TTM) Tempus|TEM - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months tempus.com|TEM - Earnings growth in current year|Expected net earnings per share growth next year Tempus AI, Inc
- sales volume and revenue information:
TEM - Company Revenue|Company Future Sales Volume Tempus Labs|TEM - Price-to-Revenue Ratio|Future Price to Revenue Tempus AI, Inc.
Fundamental company valuation:Tempus AI, Inc
Original product of Tempus

This indicator measures the percentage change in net earnings per share over a rolling twelve-month period, reflecting the business's scaling pace. The metric allows investors to assess yield sustainability and earnings volatility during shifts in market phases. For Tempus AI, Inc (TEM), under the leadership of Eric Lefkofsky, this figure confirms the effective monetization of AI algorithms in genomics. By analyzing the rolling year-over-year EPS growth trend, one can determine a safe entry point into the asset.

Direct competitors

Earnings per share for the trailing year QGEN (qiagen.com)|IONS: Net earnings per share (EPS TTM)|Repligen Corp (RGEN) - Net earnings per share (EPS TTM)|RNA (Avidity) - Net earnings per share (EPS TTM)|CRISPR (CRSP) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months WGS (GeneDx Holdings Corp.)|RARE (ultragenyx.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) BEAM (Beam Therapeutics)|Net earnings per share for the last four quarters Sarepta Therapeutics (SRPT)|TWST - Earnings per share for the last twelve months|TXG (10x) - Earnings per share for the last 12 months|NTLA: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months stoketherapeutics.com|Net earnings per share for the last 12 months BLFS|WVE (Wave Life Sciences Ltd) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) MAZE|SION - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Prime Medicine, Inc. PRME|TSHA - Net earnings per share for the last 12 months|uniQure - Net earnings per share (EPS TTM)|MGTX (MeiraGTx Holdings) - Earnings per share for the last 12 months|Regenxbio (RGNX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months SLDB|OCGN (Ocugen, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) pacb.com|Net earnings per share for the last 12 months BNTC (Benitec Biopharma)|Earnings per share for the last four quarters DSGN|Net earnings per share (EPS TTM) RCKT (Rocket Pharmaceuticals Inc)|4D Molecular Corp (FDMT) - Net earnings per one share for the last twelve months|LXEO - Earnings per share for the last twelve months|Korro Bio, Inc. (KRRO) - Net earnings per share for the last 12 months|Editas Medicine (EDIT) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months SLN (Silence Therapeutics PLC)|Net earnings per share for the last 12 months PRQR|Net earnings per share (EPS TTM) Codexis Bio|Earnings per share for the last twelve months Sangamo Therapeutics (SGMO)|Net earnings per share for the last four quarters nautilus.bio|Metagenomi - Net earnings per share for the last 12 months|Earnings per share for the trailing year DTIL|Generation Bio Corp - Net earnings per share (EPS TTM)|BOLD - Net earnings per share (EPS TTM)|XCUR: Net earnings per share (EPS TTM)|IMNN - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months PHIO|MBIO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) RNAZ|Net earnings per share for the last four quarters bionanogenomics.com|Earnings per share for the last twelve months Applied DNA Sciences APDN|BLUE: Earnings per share for the last 12 months|ImmunoPrecise - Net earnings per share (EPS TTM)|Omega Therapeutics Inc (OMGA) - Net earnings per share for the last 12 months|OMIC (Singular Genomics Systems Inc) - Net earnings per share for the last 12 months|RGLS: Earnings per share for the last four quarters|SYRS (Syros Pharmaceuticals) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months telesisbio.com TBIO|Earnings per share for the last twelve months TRACON Pharmaceuticals, Inc. (TCON)|Net earnings per share for the last 12 months Unity Biotechnology Inc. UBX